# The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye

> **NCT06043908** · PHASE4 · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** artificial tear eyedrops
- **DRUG:** 0.05% cyclosporine eyedrops

## Key facts

- **NCT ID:** NCT06043908
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-31
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06043908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06043908, "The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06043908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*